We are live on ! Find out more
ICU icon

SeaStar Medical

20 hedge funds and large institutions have $351K invested in SeaStar Medical in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

33% more funds holding

Funds holding: 1520 (+5)

0.08% more ownership

Funds ownership: 0.33%0.41% (+0.08%)

40% less capital invested

Capital invested by funds: $584K → $351K (-$233K)

Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
6
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

ICU Hedge Fund Activity: Q4 2024 in Review

20 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in SeaStar Medical (ICU) for Q4 2024, worth a combined $351K — down 40% from $584K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ICU positions and 1 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $60.2K. The largest seller was Thoroughbred Financial Services, exiting entirely with an estimated $47K sold.

  • 20 institutional investors held SeaStar Medical (ICU) as of Q4 2024, up from 15 in Q3 2024.
  • Funds reported $351K of SeaStar Medical stock for Q4 2024, down 40% quarter-over-quarter.
  • 6 funds opened new SeaStar Medical positions in Q4 2024 and 1 closed out, a net change of +5 holders.
  • The largest SeaStar Medical buyer in Q4 2024 was Vanguard Group, an estimated $60.2K added.
  • The largest SeaStar Medical seller in Q4 2024 was Thoroughbred Financial Services, an estimated $47K sold.

Based on aggregated 13F filings for Q4 2024.